RHEUMATOID ARTHRITIS-MANAGEMENT (DRUGS IN PREGNANCY)

From NeuroRehab.wiki

Revision as of 20:03, 13 March 2023 by Dr Appukutty Manickam (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

SUMMARY

1. Hydroxychloroquine and sulfasalazine are allowed during pregnancy.

2. Azathioprine, IVIG, cyclosporine A, and cyclophosphamide are relatively contraindicated (weigh risks vs. benefit).

3. Methotrexate, leflunomide, and mycophenolate mofetil are absolute contraindications.


Reference(s)

Wilkinson, I., Furmedge, D. and Sinharay, R. (2017). Oxford handbook of clinical medicine. Oxford: Oxford University Press. Get it on Amazon.
Feather, A., Randall, D. and Waterhouse, M. (2020). Kumar And Clark’s Clinical Medicine. 10th ed. S.L.: Elsevier Health Sciences. Get it on Amazon.
Hannaman, R. A., Bullock, L., Hatchell, C. A., & Yoffe, M. (2016). Internal medicine review core curriculum, 2017-2018. CO Springs, CO: MedStudy.
Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. https://www.tg.org.au [Accessed 2021].

Retrieved from "https://www.neurorehab.wiki/index.php?title=RHEUMATOID_ARTHRITIS-MANAGEMENT_(DRUGS_IN_PREGNANCY)&oldid=17933"